4
Changes in Ownership
BIOGEN INC. Filed Acc 0001127602-21-019553
Head of Research & Development sold 7,672 shares at $440.00 ($3,375,680)
From the SEC's structured data for this filing
Trades in this filing
Sandrock Alfred · Head of Research & Development
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-06-07 | Sale : show line 1 in the form | −7,672 | $440.00 | $3,375,680 | 10,169.11 | D |
| Open-market sales · 7,672 sh · avg $440.00 · $3,375,680 | ||||||
Loading xslF345X03/form4.xml…